GENEVA, Feb. 17 -- SAMJIN PHARMACEUTICAL CO., LTD. (121 Wausan-roMapo-guSeoul 04054), 삼진제약주식회사 (서울특별시마포구와우산로 121) filed a patent application (PCT/IB2025/058058) for "NAMPT INHIBITOR AND ANTIBODY-DRUG CONJUGATE CONTAINING SAME" on Aug 07, 2025. With publication no. WO/2026/033464, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): AHN, Soyeon (906ho, 202dong, 7 Dangsan-ro 42-gilYeongdeung...